001030443 001__ 1030443
001030443 005__ 20250203103347.0
001030443 037__ $$aFZJ-2024-05304
001030443 041__ $$aEnglish
001030443 1001_ $$0P:(DE-Juel1)133864$$aBeer, Simone$$b0$$eCorresponding author$$ufzj
001030443 1112_ $$aLund Glymphatic symposium$$cLund$$d2024-06-17 - 2024-06-20$$wSweden
001030443 245__ $$aExplainable AI identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden
001030443 260__ $$c2024
001030443 3367_ $$033$$2EndNote$$aConference Paper
001030443 3367_ $$2DataCite$$aOther
001030443 3367_ $$2BibTeX$$aINPROCEEDINGS
001030443 3367_ $$2DRIVER$$aconferenceObject
001030443 3367_ $$2ORCID$$aLECTURE_SPEECH
001030443 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1737639240_21941$$xAfter Call
001030443 520__ $$aAquaporin-4 (AQP4) is an integral component of the glymphatic system. Evidence exists that genetic variation of AQP4impacts Aβ clearance, clinical outcome in Alzheimer’s disease as well as sleep measures. We examined whether a risk scorecalculated from several AQP4 single-nucleotide polymorphisms (SNPs) is related to Aβ neuropathology measured by[18F]Florbetapir PET in older cognitively unimpaired individuals. In a 
001030443 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001030443 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x1
001030443 536__ $$0G:(DE-HGF)POF4-5254$$a5254 - Neuroscientific Data Analytics and AI (POF4-525)$$cPOF4-525$$fPOF IV$$x2
001030443 7001_ $$0P:(DE-Juel1)131679$$aElmenhorst, David$$b1$$ufzj
001030443 7001_ $$0P:(DE-Juel1)166265$$aBischof, Gerard Nisal$$b2$$ufzj
001030443 7001_ $$0P:(DE-HGF)0$$aRamirez, Alfredo$$b3
001030443 7001_ $$0P:(DE-Juel1)131672$$aBauer, Andreas$$b4$$ufzj
001030443 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b5$$ufzj
001030443 8564_ $$uhttps://glymphaticsymposium.com/
001030443 909CO $$ooai:juser.fz-juelich.de:1030443$$pVDB
001030443 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133864$$aForschungszentrum Jülich$$b0$$kFZJ
001030443 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131679$$aForschungszentrum Jülich$$b1$$kFZJ
001030443 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166265$$aForschungszentrum Jülich$$b2$$kFZJ
001030443 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131672$$aForschungszentrum Jülich$$b4$$kFZJ
001030443 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b5$$kFZJ
001030443 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001030443 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x1
001030443 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5254$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x2
001030443 9141_ $$y2024
001030443 920__ $$lyes
001030443 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
001030443 980__ $$aconf
001030443 980__ $$aVDB
001030443 980__ $$aI:(DE-Juel1)INM-2-20090406
001030443 980__ $$aUNRESTRICTED